Amarillo Biosciences：Amarillo Biosciences
Amarillo Biosciences
2024年6月5日—AmarilloBiosciences,Inc.isabiotechnologycompanyfocusedonimprovingimmunesystemhealthandreducinginflammationthroughthe ...。其他文章還包含有：「Ainos」、「AmarilloBiosciences」、「AmarilloBiosciencesCompanyProfile2024」、「AmarilloBiosciencesInc」、「AmarilloBiosciences宣佈計畫在臺灣臺北開設亞洲運營中心」、「AmarilloBiosciences」
查看更多 離開網站
Ainos
https://www.moneydj.com
Ainos, Inc.(AIMD.US)成立於1984年，總部位於美國加州，前身為Amarillo Biosciences, Inc.，於2021年5月更為現名，是一家多元化的醫療保健公司，主要 ...
Amarillo Biosciences
https://www.crunchbase.com
Amarillo Biosciences is a specialty biopharmaceutical company developing a patented formulation of interferon-alpha that's given orally in low doses, ...
Amarillo Biosciences Company Profile 2024
https://pitchbook.com
The company mainly focuses on the research of the treatment of human disease indications, particularly influenza, hepatitis C, thrombocytopenia, and other ...
Amarillo Biosciences Inc
https://www.linkedin.com
Website: http://amarbio.com. External link for Amarillo Biosciences Inc. Industry: Biotechnology. Company size: 11-50 employees.
Amarillo Biosciences 宣佈計畫在臺灣臺北開設亞洲運營中心
https://news.cnyes.com
德克薩斯州阿馬里洛, 2012年6月26日/美通社-PR Newswire/ -- Amarillo Biosciences, Inc.（簡稱ABI，OTCBB: AMAR）今天宣佈計畫在臺灣臺北開設亞洲 ...
Amarillo Biosciences
https://www.biospace.com
Amarillo Biosciences, Inc. Announced Closing under Securities Purchase Agreement with Majority Investor and Name Change to Ainos, Inc..